AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 43 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,961,000 | +61.7% | 580,000 | +132.0% | 1.85% | +114.2% |
| Q3 2021 | $2,450,000 | -35.1% | 250,000 | -55.4% | 0.86% | -42.7% |
| Q2 2021 | $3,776,000 | -61.9% | 561,011 | -48.8% | 1.51% | -57.7% |
| Q1 2021 | $9,899,000 | +110.1% | 1,095,000 | +55.3% | 3.57% | +178.4% |
| Q4 2020 | $4,711,000 | +32.6% | 705,218 | 0.0% | 1.28% | +32.8% |
| Q3 2020 | $3,554,000 | -74.9% | 705,218 | -59.8% | 0.96% | -76.4% |
| Q2 2020 | $14,158,000 | -32.4% | 1,752,218 | -34.5% | 4.09% | -59.7% |
| Q1 2020 | $20,949,000 | +70.7% | 2,673,718 | +64.5% | 10.15% | +234.2% |
| Q4 2019 | $12,269,000 | – | 1,625,000 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |